The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine

Human Psychopharmacology

Volumn 26, Issue 6, 2011, Pages 392-396

  Zhang, Ruiling ^a   Hao, Wei ^a   Pan, Miao ^a   Wang, Chuansheng ^a   Zhang, Xiuli ^a   Chen, Da Chun ^b   Xiu, Mei Hong ^b   De Yang, Fu ^b   Kosten, Thomas R ^c   Zhang, Xiang Yang ^b,c  

^a 2nd Hospital Affiliated to Xinxiang Medical University   (China)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

antipsychotic drug; clozapine; diabetes mellitus; prevalence; schizophrenia

Indexed keywords

CLOZAPINE;

ADULT; AGED; ARTICLE; BODY MASS; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIAGNOSTIC INTERVIEW SCHEDULE; DIET RESTRICTION; DISEASE ASSOCIATION; EDUCATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; NATURALISTIC INQUIRY; ORAL GLUCOSE TOLERANCE TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; AGE FACTORS; AGED; ANTIPSYCHOTIC AGENTS; BLOOD GLUCOSE; BODY MASS INDEX; CHINA; CHRONIC DISEASE; CLOZAPINE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SCHIZOPHRENIA;

EID: 80052268695     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.1220     Document Type: Article

References (29)

1. Buse JB, Cavazzoni P, Hornbuckle K, Hutchins D, Breier A, Jovanovic L,. 2003. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol 56: 164-170. (Pubitemid 36315943)
2. Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B,. 2001. Effectiveness of second generation antipsychotics in patients with treatment-resistant schizophrenia, a review and meta-analysis of randomized trials. Am J Psychiatry 158: 518-526. (Pubitemid 32289814)
3. Citrome LL,. 2004. The increase in risk of diabetes mellitus from exposure to second-generation antipsychotic agents. Drugs Today 40: 445-464. (Pubitemid 38858911)
4. Citrome LL, Jaffe AB,. 2003. Relationship of atypical antipsychotics with development of diabetes mellitus. Ann Pharmacother 37: 1849-1857. (Pubitemid 37466585)
5. Citrome LL, Holt RI, Zachry WM, et al,. 2007. Risk of treatment-emergent diabetes mellitus in patients receiving antipsychotics. Ann Pharmacother 41: 1593-1603. (Pubitemid 47479787)
6. DeFronzo RA,. 2004. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88: 787-835.
7. Dixon L, Weiden P, Delahanty J, et al,. 2000. Prevalence and correlates of diabetes in national schizophrenia samples. Schizophr Bull 26: 903-912.
8. Gianfrancesco FD, Grogg AL, Mahmoud RA, Wang RH, Nasrallah HA,. 2002. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database. J Clin Psychiatry 63: 920-930. (Pubitemid 35231733)
9. Glazer WM, Dickson RA,. 1998. Clozapine reduces violence and persistent aggression in schizophrenia. J Clin Psychiatry 59 (Suppl 3): 8-14. (Pubitemid 28196364)
10. Hägg S, Joelsson L, Mjörndal T, Spigset O, Oja G, Dahlqvist R,. 1998. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications. J Clin Psychiatry 59: 294-299. (Pubitemid 28353977)
11. Henderson DC, Cagliero E, Gray C, et al,. 2000. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am J Psychiatry 157: 975-981. (Pubitemid 30412350)
12. Kane JM,. 1992. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Br J Psychiatry 17 (Suppl): 41-45.
13. Koller E, Schneider B, Bennett K, Dubitsky G,. 2001. Clozapine-associated diabetes. Am J Med 111: 716-723. (Pubitemid 34017524)
14. Lamberti JS, Costea GO, Olson D, et al,. 2005. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates. J Clin Psychiatry 66: 900-906. (Pubitemid 41032832)
15. Lindenmayer JP, Czobor P, Volavka J, et al,. 2003. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Am J Psychiatry 160: 290-296. (Pubitemid 41110454)
16. Lund BC, Perry PJ, Brooks JM, Arndt S,. 2001. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. Arch Gen Psychiatry 58: 1172-1176. (Pubitemid 33121510)
17. McCarthy MI,. Genomics, type 2 diabetes, and obesity. N Engl J Med 2010; 363 (24): 2339-2350.
18. Meltzer HY,. 1998. Suicide in schizophrenia: risk factors and clozapine treatment. J Clin Psychiatry 59 (Suppl 3): 15-20. (Pubitemid 28196365)
19. Mukherjee S, Decina P, Bocola V, Saraceni F, Scapicchio PL,. 1996. Diabetes mellitus in schizophrenic patients. Compr Psychiatry 37: 68-73. (Pubitemid 26024880)
20. Mukherjee S, Schnur DB, Reddy R,. 1989. Family history of type 2 diabetes in schizophrenic patients. Lancet 1 (8636): 495. (Pubitemid 19063553)
21. Nielsen J, Skadhede S, Correll CU,. 2010. Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients. Neuropsychopharmacology 35 (9): 1997-2004.
22. Sernyak MJ, Gulanski B, Leslie DL, Rosenheck R,. 2003. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia. J Clin Psychiatry 64: 605-608. (Pubitemid 36618292)
23. Smith M, Hopkins D, Peveler RC, Holt RI, Woodward M, Ismail K,. 2008. First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 192: 406-411. (Pubitemid 351809892)
24. Starrenburg FC, Bogers JP,. 2009. How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins. Eur Psychiatry 24: 164-170.
25. Tandon R, Belmaker RH, Gattaz WF, et al,. 2008. World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophr Res 100: 20-38.
26. Tang YL, Mao PX, Jiang F, et al,. 2008. Clozapine in China. Pharmacopsychiatry 41: 1-9. (Pubitemid 351195886)
27. Wang PS, Glynn RJ, Ganz DA, Schneeweiss S, Levin R, Avorn J,. 2002. Clozapine use and risk of diabetes mellitus. J Clin Psychopharmacol 22: 236-243. (Pubitemid 34546837)
28. Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC,. 1998. Novel antipsychotics and new onset diabetes. Biol Psychiatry 44: 778-783. (Pubitemid 28496795)
29. Yood MU, DeLorenze G, Quesenberry CP, Jr. , et al,. 2009. The incidence of diabetes in atypical antipsychotic users differs according to agent - results from a multisite epidemiologic study. Pharmacoepidemiol Drug Saf 18: 791-799.